Is there a role for screening spirometry?

Respiratory Care

Volumn 55, Issue 1, 2010, Pages 35-40

  MacIntyre, Neil R ^a   Selecky, Paul A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Hoag Hospital   (United States)

Author keywords

Chronic obstructive pulmonary disease; Screening tests; Smoking cessation; Spirometry

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; OUTCOME ASSESSMENT; SCREENING TEST; SMOKING CESSATION; SPIROMETRY; VITAL CAPACITY; VITAL SIGN;

FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MASS SCREENING; SPIROMETRY; VITAL CAPACITY;

EID: 75749117949     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
2. Hankinson JL, Odencranz JR, Fedan FB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179-187.
3. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
4. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated November 2008. http://www.goldcopd.org/ guidelineitem.asp? l1=2&l2=1&intid=2003 Accessed November 4, 2009.
5. Crapo RO, Jensen RL. Standards and interpretive issues in lung function testing. Respir Care 2003;48(8):764-772.
6. Brown DW, Croft JB, Greenlund KJ, et al. Deaths from chronic obstructive pulmonary disease - United States, 2000-2005. MMWR Weekly, November 14, 2008;57:1229-1232.
7. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946. Erratum in: Eur Respir J 2006;27(1):242.
8. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294(10):1255-1259.
9. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 147(9):633-638.
10. Wood Ann, Stockley RA. The genetics of chronic obstructive pulmonary disease. Respir Res 2006;7:130-144.
11. Zielinski J, Bednarek M; Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometry screening. Chest 2001;119(3):731-736.
12. Stratelis G, Jakobsson P, Mölstad S, Zetterström O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004;54(500):201-206.
13. Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim Care Respir J 2007; 16(1):41-48.
14. Castilio D, Guayta R, Giber J, Burgos F, Capdevila C, Soriano JB, et al; FARMAEPOC Group. COPD case finding for spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med 2009;103(6):839-845.
15. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006;51(10):1120-1124.
16. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1(6077):1645-1648.
17. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61(10):869-873.
18. Górecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003; 123(6):1916-1923.
19. Lee TA, Bartle B, Weiss KS. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006;129(6):1509-1515.
20. Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ. Spirometry utilization for COPD: how do we measure up? Chest 2007;132(2):403-409.
21. Gardner RM, Clausen JL, Epler G, Hankinson JL, Permutt S, Plummer AL. Pulmonary function laboratory personnel qualifications. Am Rev Respir Dis 1986;134(3):623-624.
22. The National Lung Health Education Program (NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest 1998;113(2 Suppl):123S-163S.
23. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care 2000;45(5): 513-530.
24. Eaton T, Withy S, Garrett J, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116(2): 416-423.
25. Hankinson JL. Office spirometry: does poor quality render it impractical? Chest 1999;116(2):276-277.
26. White P, Wong W, Fleming T, Gray B. Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Brit J Gen Pract 2007; 57(542):701-705.
27. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baked R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax 2008; 63(5):408-414.
28. Enright P. Provide GPs with spirometry, not spirometers. Thorax 2008;63(5):387-388.
29. 1/FVC ratio below the fifth percentile, not < 70%. Chest 2007;131(2):349-355.
30. Collen J, Greenburg D, Holley A, King CS, Hnatiuk O. Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III. Chest 2008;134(5):1009- 1016.
31. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest 2006;129(4): 833-835.
32. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest 2000;117(2 Suppl):15S-19S.
33. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000;321(7257):355-358.
34. Stratelis G, Mölstad S, Jakobsson P, Zetterström O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scan J Prim Health Care 2006;24(3):133-139.
35. 1 and asbestos exposure. Eur Respir J 1998;11(2):284-290.
36. Buffels J, Degryse J, Decramer J, Heyrman J. Spirometry and smoking cessation advice in general practice: a randomized clinical trial. Respir Med 2006;100(11):2012-2017.
37. Sippel JM, Osborne ML, Bjornson W, Goldberg B, Buist AS. Smoking cessation in primary care clinics. J Gen Int Med 1999;14(11): 670-676.
38. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking, Arch Int Med 1995;155(18): 1933-1941.
39. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB; US Preventative Services Task Force. Screening for COPD using spirometry: summary of the evidence for the US Preventive Services Task Force. Ann Int Med 2008;148(7):535-543.